Literature DB >> 31522247

The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system.

Takayuki Yabe1,2, Toshiya Muramatsu3, Reiko Tsukahara3, Masatsugu Nakano3, Hideyuki Takimura3, Mami Kawano3, Tasuku Hada3, Takanori Ikeda4.   

Abstract

The dynamic coronary roadmap (DCR) is a novel technology that creates a dynamic, motion-compensated, real-time overlay of the coronary arteries on a fluoroscopic image. Whether the DCR reduces contrast volume and enables safe and effective treatment was examined. A total of 146 patients undergoing percutaneous coronary intervention (PCI) from June 2017 to September 2017 in our hospital were retrospectively evaluated. Chronic total occlusion lesions, acute coronary syndrome, and hemodialysis patients were excluded. Patients were divided into the control group (PCI without DCR, 92 patients, 103 lesions) and the DCR group (38 patients, 43 lesions). The primary endpoint was contrast medium volume, and secondary endpoints were radiation dose, fluoroscopy time, and clinical success rate. There was no significant difference in the success rate (100% vs. 100%, P = 1.000) between the groups. Fluoroscopy time (16.3 ± 11.2 min. vs. 11.4 ± 5.5 min, P = 0.007) and contrast medium volume (152.1 ± 73.0 ml vs. 118.8 ± 49.7 ml, P = 0.006) were significantly lower in the DCR group than in the control group. DCR use during PCI was associated with a significant reduction in contrast volume and fluoroscopy time compared to a control group despite similar clinical, lesion, and procedural characteristics.

Entities:  

Keywords:  Angiographic systems; Contrast medium volume; Percutaneous coronary intervention; Stable angina

Mesh:

Substances:

Year:  2019        PMID: 31522247     DOI: 10.1007/s00380-019-01502-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

1.  Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration.

Authors:  Keyvan Karimi Galougahi; Adrian Zalewski; Martin B Leon; Dimitri Karmpaliotis; Ziad A Ali
Journal:  Eur Heart J       Date:  2015-12-18       Impact factor: 29.983

Review 2.  Contrast-induced nephropathy: a clinical and evidence-based approach.

Authors:  Martin Tepel; Peter Aspelin; Norbert Lameire
Journal:  Circulation       Date:  2006-04-11       Impact factor: 29.690

3.  Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome.

Authors:  Eliano Pio Navarese; Volker Schulze; Felicita Andreotti; Mariusz Kowalewski; Michalina Kołodziejczak; David E Kandzari; Tienush Rassaf; Bartosz Gorny; Maximilian Brockmeyer; Christian Meyer; Sergio Berti; Jacek Kubica; Malte Kelm; Marco Valgimigli
Journal:  JACC Cardiovasc Interv       Date:  2014-11-01       Impact factor: 11.195

4.  A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity.

Authors:  Hariprasad S Trivedi; Harold Moore; Samer Nasr; Kul Aggarwal; Alok Agrawal; Punit Goel; John Hewett
Journal:  Nephron Clin Pract       Date:  2003-01

5.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

Authors:  T J Ryan; D P Faxon; R M Gunnar; J W Kennedy; S B King; F D Loop; K L Peterson; T J Reeves; D O Williams; W L Winters
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

Review 6.  Long-Term Follow-Up of Patients at High Risk for Nephropathy After Contrast Exposure.

Authors:  Okay Abaci; Ozlem Harmankaya; Betul Kocas; Cuneyt Kocas; Cem Bostan; Ugur Coskun; Ahmet Yildiz; Murat Ersanli
Journal:  Angiology       Date:  2014-08-12       Impact factor: 3.619

7.  Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.

Authors:  E C Lasser; S G Lyon; C C Berry
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

8.  Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?

Authors:  Jeremiah R Brown; John F Robb; Clay A Block; Anton C Schoolwerth; Aaron V Kaplan; Gerald T O'Connor; Richard J Solomon; David J Malenka
Journal:  Circ Cardiovasc Interv       Date:  2010-06-29       Impact factor: 6.546

9.  Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.

Authors:  Hitinder S Gurm; Milan Seth; Simon R Dixon; P Michael Grossman; Devraj Sukul; Thomas Lalonde; Louis Cannon; Daniel West; Ryan D Madder; D Adam Lauver
Journal:  Catheter Cardiovasc Interv       Date:  2018-08-25       Impact factor: 2.692

10.  Nephrotoxic effects in high-risk patients undergoing angiography.

Authors:  Peter Aspelin; Pierre Aubry; Sven-Göran Fransson; Ruth Strasser; Roland Willenbrock; Knut Joachim Berg
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.